Rey-Bedon, C. Et Al. 2022. CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver. BIOMEDICINE & PHARMACOTHERAPY , vol.146 .

Rey-Bedon, C., Banik, P., Gokaltun, A., Hofheinz, O., Yarmush, M. L., Uygun, M. K., ... Usta, O. B.(2022). CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver. BIOMEDICINE & PHARMACOTHERAPY , vol.146.

Rey-Bedon, Camilo Et Al. "CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver," BIOMEDICINE & PHARMACOTHERAPY , vol.146, 2022

Rey-Bedon, Camilo Et Al. "CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver." BIOMEDICINE & PHARMACOTHERAPY , vol.146, 2022

Rey-Bedon, C. Et Al. (2022) . "CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver." BIOMEDICINE & PHARMACOTHERAPY , vol.146.

@article{article, author={Camilo Rey-Bedon Et Al. }, title={CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver}, journal={BIOMEDICINE & PHARMACOTHERAPY}, year=2022}